No significant change of liver, renal function, blood sugar, blood lipid, electrolyte and blood routine test were occurred in carvedilol group.
最常见的不良反应是头晕，未出现肝、肾功能损害及血脂、血糖、电解质和血象的变化。
In 62 recipients (93.9%) of group b, the abnormal renal function was completely reversed after anti-rejection treatment.
组接受抗排斥治疗后，62例(93.9%)患者肾功能完全逆转。
The blood pressure, nutritional status(ferrohemoglobin and serum albumin level) and renal function(plasma creatinine level) were same in PCRT group compared with control group pretransplantation.
移植前无透析组的血压、营养状况（血红蛋白和白蛋白水平）及肾功能（血肌酐水平）与对照组无差异。
Results Renal function injury rate of A Group was 6.67%, B Group was 21.05%(P<0.01).
结果阿拓木兰组中出现肾功能损害为6.67%，对照组肾功能损害为21.05%（P<0.01）。
In aorta balloon block group, 1 died of lung metastasis. No damnification of adjacent organs or ischemic necrosis or failure of renal function happened.
球囊阻断组，1例发生肺转移死亡，所有病人均无邻近脏器损伤、肢体远端缺血坏死、肾功能损伤等并发症。
In aorta balloon block group, 1 died of lung metastasis. No damnification of adjacent organs or ischemic necrosis or failure of renal function happened.
球囊阻断组，1例发生肺转移死亡，所有病人均无邻近脏器损伤、肢体远端缺血坏死、肾功能损伤等并发症。
应用推荐